[go: up one dir, main page]

PT957920E - Reducao dos efeitos toxicos de carboplatina utilizando ditioeteres - Google Patents

Reducao dos efeitos toxicos de carboplatina utilizando ditioeteres

Info

Publication number
PT957920E
PT957920E PT97941110T PT97941110T PT957920E PT 957920 E PT957920 E PT 957920E PT 97941110 T PT97941110 T PT 97941110T PT 97941110 T PT97941110 T PT 97941110T PT 957920 E PT957920 E PT 957920E
Authority
PT
Portugal
Prior art keywords
carboplatin
dithioether
ditioeters
reducing
toxic effects
Prior art date
Application number
PT97941110T
Other languages
English (en)
Inventor
Frederick Herman Hausheer
Kochat Haridas
Dasharatha Gauravaram Reddy
Peddaiahgari Seetharamulu
Dhanabalan Murali
Original Assignee
Bionumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionumerik Pharmaceuticals Inc filed Critical Bionumerik Pharmaceuticals Inc
Publication of PT957920E publication Critical patent/PT957920E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT97941110T 1996-09-23 1997-09-23 Reducao dos efeitos toxicos de carboplatina utilizando ditioeteres PT957920E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2643096P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
PT957920E true PT957920E (pt) 2002-06-28

Family

ID=21831779

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97941110T PT957920E (pt) 1996-09-23 1997-09-23 Reducao dos efeitos toxicos de carboplatina utilizando ditioeteres

Country Status (11)

Country Link
EP (1) EP0957920B1 (pt)
JP (3) JP2001500872A (pt)
CN (1) CN1129432C (pt)
AT (1) ATE210987T1 (pt)
AU (1) AU712548B2 (pt)
CA (1) CA2263166C (pt)
DE (1) DE69709404T2 (pt)
DK (1) DK0957920T3 (pt)
ES (1) ES2170414T3 (pt)
PT (1) PT957920E (pt)
WO (1) WO1998011898A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177411B1 (en) * 1999-02-09 2001-01-23 Bionumerik Pharmaceuticals, Inc. Method for treating heavy metal poisoning
ES2261399T3 (es) 2000-04-26 2006-11-16 Oregon Health Sciences University Administracion de un compuesto quimioprotector que contiene tiol.
JP2004523518A (ja) * 2001-01-19 2004-08-05 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド より効能が大きく副作用の少ない癌治療方法
US8710095B2 (en) 2002-04-30 2014-04-29 Bionumerik Pharmaceuticals, Inc. Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
US7282602B2 (en) * 2004-09-21 2007-10-16 Bionumerik Pharmaceuticals, Inc. Medicinal disulfide salts
JP5694782B2 (ja) * 2008-03-14 2015-04-01 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 肺癌、腺癌及び他の病状のための治療方法及び組成物
CN111632146B (zh) * 2020-05-29 2021-09-28 中山大学 Oat抑制剂和溶瘤病毒在制备抗肿瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789000A (en) * 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum

Also Published As

Publication number Publication date
CA2263166C (en) 2006-12-12
ES2170414T3 (es) 2002-08-01
AU712548B2 (en) 1999-11-11
ATE210987T1 (de) 2002-01-15
AU4313397A (en) 1998-04-14
JP2009143950A (ja) 2009-07-02
JP2013155200A (ja) 2013-08-15
WO1998011898A1 (en) 1998-03-26
EP0957920A1 (en) 1999-11-24
DE69709404T2 (de) 2002-05-29
DE69709404D1 (de) 2002-01-31
CN1230887A (zh) 1999-10-06
CN1129432C (zh) 2003-12-03
CA2263166A1 (en) 1998-03-26
DK0957920T3 (da) 2002-04-02
JP2001500872A (ja) 2001-01-23
EP0957920B1 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
DE69615808D1 (de) Camphothecinderivate
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
YU39695A (sh) Formulacija analoga insulina
KR890011902A (ko) 디데옥시디데히드로카르보시클릭 뉴클레오시드
ATE174899T1 (de) Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
FR2657526B1 (fr) Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
DK0792154T3 (da) Sammensætning af cisplatin i kombination med 2,2'-dithio-bis(ethansulfonat) (dimesna)
ES2127397T3 (es) Sulfonamidas y sus derivados que modulan la actividad de la endotelina.
NO975632D0 (no) Dinukleotider som er nyttige for behandling av lungesykdom
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
RU99112577A (ru) Новое применение 1,3-пропандиольных производных
FR2635104B1 (fr) Derives d'indolone, leur preparation et leur application en therapeutique
SE9002500L (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
CA2250861A1 (en) Cyclic adhesion inhibitors
PT957920E (pt) Reducao dos efeitos toxicos de carboplatina utilizando ditioeteres
KR970025615A (ko) 암 전이 억제제
ES2142773A1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
KR900016238A (ko) 신규 화합물
BR9915546A (pt) Terapia de combinação de ribavirin- interferon alfa para a erradiação de hcv-rna detectável em pacientes tendo infecção por hepatite c crÈnica
AR017640A1 (es) Un derivado de carbohidratos, su uso y una composicion farmaceutica que lo comprende
KR950016760A (ko) 치질 치료제
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende